Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04905069 · ClinicalTrials.gov registry record · NA

Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer

A NA study of Prostate Cancer, sponsored by Boston Scientific Corporation.

Active
Registry status
NA
Development phase
500
Enrollment target
20
Study locations

NCT04905069 is a NA study of Prostate Cancer that is active but no longer recruiting, run by Boston Scientific Corporation. The registered enrollment target is 500 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (18% lower). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04905069, a NA study of Prostate Cancer, is active but no longer recruiting, sponsored by Boston Scientific Corporation.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
500 participants
Enrollment target
20
Study locations

Study Summary

To demonstrate the effectiveness of the SpaceOAR Vue System in reducing late gastrointestinal (GI) toxicity in subjects undergoing Stereotactic Body Radiotherapy (SBRT) to treat prostate cancer.

Conditions Studied

Prostate Cancer

Interventions

  • DEVICE SpaceOAR Vue System

Study Locations (20)

Other

  • Institut de Radiothérapie & Radiochirurgie HARTMANN - Levallois-Perret
  • MEDICLIN Robert Janker Klinik - Bonn
  • Klinikum Nurnberg Nord - Nuremberg
  • Bon Secours Radiotherapy Cork - Cork
  • Azienda Ospedaliero Universitaria di Parma - Parma
  • Policlinico Universitario Agostino Gemelli - Rome
  • IRCCS Ospedale Sacro Cuore Don Calabria - Verona
  • Hospital Universitario Cruces - Barakaldo
  • GenesisCare, Hospital San Francisco de Asis - Madrid

Florida

  • GenesisCare USA - Fort Myers
  • Florida Urology Partners, LLC - Tampa

Kansas

  • Kansas University Medical Center - Kansas City

Michigan

  • GenesisCare USA - Troy

New Jersey

  • New Jersey Urology, a Summit Health Company - Bloomfield

Pennsylvania

  • University of Pittsburgh Medical Center - Pittsburgh

South Carolina

  • Dr. John Sylvester - Myrtle Beach

New South Wales

  • Calvary Mater Newcastle - Waratah

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2021-12-21
Est. Completion 2030-04
Phase NA

Sponsor

Boston Scientific Corporation

280 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04905069

The ClinicalTrials.gov registry entry for NCT04905069 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (18% lower). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 1 intervention - of which SpaceOAR Vue System is the first listed.

NCT04905069 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Other, Florida, Kansas.

Frequently Asked Questions

What is clinical trial NCT04905069 about?

NCT04905069 is a clinical study titled "Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer". To demonstrate the effectiveness of the SpaceOAR Vue System in reducing late gastrointestinal (GI) toxicity in subjects undergoing Stereotactic Body Radiotherapy (SBRT) to treat prostate cancer.

What is the current status of trial NCT04905069?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2021-12-21. Estimated completion is 2030-04.

What conditions does trial NCT04905069 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT04905069?

The interventions under investigation include: SpaceOAR Vue System (DEVICE).

Who is sponsoring clinical trial NCT04905069?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04905069 being conducted?

This trial has 20 study locations across Florida, Kansas, Michigan, New Jersey, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.